Chemical and biochemical studies of 2-propynylpyrrolidine derivatives. Restricted-rotation analogs of N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide (BM-5)
- 1 December 1990
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 33 (12) , 3190-3198
- https://doi.org/10.1021/jm00174a015
Abstract
A series of optically pure 2-[substituted-3-aminopropynyl]pyrrolidine derivatives, which are restricted-rotation analogues of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide (BM-5, compound 1), have been prepared from d- and l-proline. The compounds when tested in a series of in vitro muscarinic assays [[3H]CD (cortex), [3H]QNB (cortex), [3H]PZ (cortex), [3H]QNB (heart), [3H]QNB + GppNHp (heart)] were found to have weaker muscarinic properties than compound 1. The decrease in affinity was attributed to the increased size of the molecule resulting from the addition of a methylene group to form the pyrrolidine ring. The use of optically active compounds provided a more detailed examination of the complex pharmacological effects of the flexible muscarinic agent 1. The R enantiomers in the acetamide derivatives 12b, 12d, and 12f had a 5-10-fold greater affinity for the muscarinic receptor than the corresponding S enantiomers. A 5-fold difference or less found in the (R)- and (S)-carbamate derivatives 9, 15, and 16 suggested close overlap of the two enantiomers in the receptor binding domain. The affinity differences found in the enantiomeric acetamido derivatives when compared to those of the carbamate analogues may be the result of limited rotation of the acetamido group.This publication has 16 references indexed in Scilit:
- [H-3] PIRENZEPINE AND (-)-[H-3]QUINUCLIDINYL BENZILATE BINDING TO RAT CEREBRAL CORTICAL AND CARDIAC MUSCARINIC CHOLINERGIC SITES .1. CHARACTERIZATION AND REGULATION OF AGONIST BINDING TO PUTATIVE MUSCARINIC SUBTYPES1986
- [H-3] PIRENZEPINE AND (-)-[H-3]QUINUCLIDINYL BENZILATE BINDING TO RAT CEREBRAL CORTICAL AND CARDIAC MUSCARINIC CHOLINERGIC SITES .2. CHARACTERIZATION AND REGULATION OF ANTAGONIST BINDING TO PUTATIVE MUSCARINIC SUBTYPES1986
- Action of agonists and antagonists at muscarinic receptors present on ileum and atria in vitroBritish Journal of Pharmacology, 1985
- PHARMACOLOGICAL DIFFERENCES BETWEEN THE HIGH-AFFINITY MUSCARINIC AGONIST BINDING STATES OF THE RAT-HEART AND CEREBRAL-CORTEX LABELED WITH (+)-[H-3]CISMETHYLDIOXOLANE1984
- Recognition of cholinergic agonists by the muscarinic receptor. 1. Acetylcholine and other agonists with the NCCOCC backboneJournal of Medicinal Chemistry, 1983
- A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypesLife Sciences, 1983
- [3H] pirenzepine selectively identifies a high affinity population of muscarinic cholinergic receptors in the rat cerebral cortexLife Sciences, 1982
- Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal ForebrainScience, 1982
- LIGAND: A versatile computerized approach for characterization of ligand-binding systemsAnalytical Biochemistry, 1980
- MOLECULAR ORBITAL CALCULATION OF PREFERRED CONFORMATIONS OF ACETYLCHOLINE MUSCARINE AND MUSCARONE1967